Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis...

Area of Science:

• Immunology
• Rheumatology
• Clinical Medicine

Background:

• Systemic sclerosis (SSc) is a complex autoimmune disease characterized by autoantibodies.
• Understanding the relationships between different SSc autoantibodies and their clinical manifestations is crucial for patient management.

Purpose of the Study:

• To investigate the associations between various SSc-related autoantibodies.
• To determine the clinical correlations of these autoantibody clusters in an Australian patient cohort.

Main Methods:

• Serum samples from 505 Australian SSc patients were analyzed for multiple autoantibodies using line immunoassay.
• Hierarchical clustering and principal components analysis were employed to identify patient subgroups based on autoantibody scores.
• Clinical data was systematically compared with autoantibody profiles.

Main Results:

• 449 out of 505 patients tested positive for at least one autoantibody.
• Strong, mutually exclusive relationships were observed between antibodies to centromere proteins (CENP), RNA polymerase III (RNAP III), and topoisomerase I (topo I).
• Five distinct autoantibody clusters were identified, with novel findings including the statistical separation of RNAP III into strong and weak clusters, each associated with unique clinical features.

Conclusions:

• Five major autoantibody clusters with distinct serologic and clinical associations were identified in Australian SSc patients.
• Autoantibody subclassification and disease stratification show potential clinical utility, particularly for early SSc diagnosis and management.